Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegcrisantaspase in ALL/LBL with Hypersensitivity to Pegaspargase
NCT02257684Phase 2Terminated
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Sep 2014
- Primary completion
- Feb 2015
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegcrisantaspase in acute lymphoblastic leukemia (ALL), lymphoblastic lymphoma (LL), sponsored by Jazz Pharmaceuticals plc. Started Sep 2014; status: terminated.
02
Drugs
pegcrisantaspase
03
Conditions
acute lymphoblastic leukemia (ALL)lymphoblastic lymphoma (LL)
Beyond the preview
Go deeper on NCT02257684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02257684.